367 related articles for article (PubMed ID: 2969976)
1. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
Chen YF; Jin HK; Paul R; Nagahama S
J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
[TBL] [Abstract][Full Text] [Related]
2. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
Nagahama S; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
[TBL] [Abstract][Full Text] [Related]
4. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
Chen YF; Oparil S
Brain Res; 1987 Jan; 400(2):225-31. PubMed ID: 2949797
[TBL] [Abstract][Full Text] [Related]
5. Blunted responsiveness of posterior hypothalamic norepinephrine to quinpirole in DOCA/NaCl hypertensive rats.
Chen YF; Jin HK; Gist R; Oparil S
Brain Res Bull; 1987 Apr; 18(4):563-8. PubMed ID: 2440528
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
Nagahama S; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1986 Nov; 239(2):426-32. PubMed ID: 3772802
[TBL] [Abstract][Full Text] [Related]
7. Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats.
Chen YF; Jin HK; Gist R; Oparil S
Brain Res; 1987 Jun; 413(1):15-22. PubMed ID: 2954616
[TBL] [Abstract][Full Text] [Related]
8. Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
Damase-Michel C; Montastruc JL; Gharib C; Geelen G; De Saint-Blanquat G; Tran MA
J Pharmacol Exp Ther; 1990 Feb; 252(2):770-7. PubMed ID: 1968975
[TBL] [Abstract][Full Text] [Related]
9. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Lahlou S
Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
[TBL] [Abstract][Full Text] [Related]
10. Prolonged central effects of quinpirole on cardiovascular regulation.
van den Buuse M; Morton SJ; Cornish JL; Head GA
J Pharmacol Exp Ther; 1996 Apr; 277(1):473-83. PubMed ID: 8613956
[TBL] [Abstract][Full Text] [Related]
11. Continuous intravenous infusion of LY171555, a potent selective D2 receptor agonist, lowers blood pressure in the conscious rat.
Igarashi Y; Chen YF; Wyss JM; Lindheimer MD; Oparil S
Pharmacology; 1987; 35(4):194-202. PubMed ID: 2959969
[TBL] [Abstract][Full Text] [Related]
12. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
Pesonen A; Leppäluoto J; Ruskoaho H
J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
[TBL] [Abstract][Full Text] [Related]
14. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.
Zukowska-Grojec Z; Haass M; Kopin IJ; Zamir N
J Pharmacol Exp Ther; 1986 Nov; 239(2):480-7. PubMed ID: 2877083
[TBL] [Abstract][Full Text] [Related]
15. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats.
van den Buuse M
J Pharmacol Exp Ther; 1992 Jul; 262(1):303-11. PubMed ID: 1352551
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular responses to intrathecal dopamine receptor agonists in conscious DOCA-salt hypertensive rats.
Lahlou S
Fundam Clin Pharmacol; 1999; 13(6):624-34. PubMed ID: 10626749
[TBL] [Abstract][Full Text] [Related]
17. Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats.
Linthorst AC; De Lang H; De Jong W; Versteeg DH
Eur J Pharmacol; 1991 Aug; 201(2-3):125-33. PubMed ID: 1686754
[TBL] [Abstract][Full Text] [Related]
18. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure effects of intravenous apomorphine in conscious deoxycorticosterone-acetate salt-hypertensive rats.
Toscano CF; Lahlou S
J Cardiovasc Pharmacol; 2003 Dec; 42(6):772-81. PubMed ID: 14639100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
